Literature DB >> 8473481

Vitamin K nutrition and postmenopausal osteoporosis.

P A Price.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8473481      PMCID： PMC288094          DOI： 10.1172/JCI116324

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  3 in total

1.  Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women.

Authors:  P Szulc; M C Chapuy; P J Meunier; P D Delmas
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

2.  The effect of vitamin K supplementation on circulating osteocalcin (bone Gla protein) and urinary calcium excretion.

Authors:  M H Knapen; K Hamulyák; C Vermeer
Journal:  Ann Intern Med       Date:  1989-12-15       Impact factor: 25.391

3.  Dietary induced subclinical vitamin K deficiency in normal human subjects.

Authors:  G Ferland; J A Sadowski; M E O'Brien
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808
  3 in total
  3 in total

1.  Estimating the causal effect of milk powder supplementation on bone mineral density: a randomized controlled trial with both non-compliance and loss to follow-up.

Authors:  Y Chen; Q Zhang; Y Wang; Y Xiao; R Fu; H Bao; M Liu
Journal:  Eur J Clin Nutr       Date:  2015-01-28       Impact factor: 4.016

2.  Vitamin K treatment reduces undercarboxylated osteocalcin but does not alter bone turnover, density, or geometry in healthy postmenopausal North American women.

Authors:  Neil Binkley; Judith Harke; Diane Krueger; Jean Engelke; Nellie Vallarta-Ast; Dessa Gemar; Mary Checovich; Richard Chappell; John Suttie
Journal:  J Bone Miner Res       Date:  2009-06       Impact factor: 6.741

3.  Correlation of undercarboxylated osteocalcin (ucOC) concentration and bone density with age in healthy Korean women.

Authors:  Sang-Man Kim; Kwang-Min Kim; Bom-Taeck Kim; Nam-Seok Joo; Kyu-Nam Kim; Duck-Joo Lee
Journal:  J Korean Med Sci       Date:  2010-07-21       Impact factor: 2.153
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.